USPTO trademark

FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT

RegisteredUSPTOWord and designClass 35Class 44

"FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT" is a word and design mark owned by Fennec Pharmaceuticals, Inc., filed at the USPTO on June 21, 2022. It is registered and covers classes 35 and 44.

View Fennec Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT trademark as filed
As filed with the USPTO
Status
Registered
Since January 23, 2024
Filed
June 21, 2022
Registered
January 23, 2024
Expires
Not recorded
Application no.
97467771
Registration no.
7288670
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
2 classes
Ownership

Who owns FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Fennec Pharmaceuticals, Inc.

FENC · Research Triangle Park, United States

5 trademarks in the portfolioView company

Representative

Joseph E. Washington

Morgan, Lewis & Bockius LLP

Goods and services

What the mark covers

The products and services FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT is filed for, grouped by Nice class.

  • Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportunities for underserved and needy communities by means of public advocacy and business administration of the patient assistance programs of others by enrolling patients in the assistance programs to assist them in saving money on their prescription medications; business administration of patient pharmaceutical reimbursement programs; business administration of a patient support and assistance program for obtaining reimbursement for prescription medicines

  • Providing medical information and educational information in the field of medicine about the treatment and prevention of ototoxicity from cisplatin in pediatric patients

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Case assigned to intent to use paralegal
  7. Use amendment filed
  8. Teas statement of use received
  9. Noa e-mailed - sou required from applicant
  10. Official gazette publication confirmation e-mailed

10 earlier steps on the official record.

FAQ

About FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT

Who owns the trademark "FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT"?

The USPTO trademark "FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT" (application 97467771) is owned by Fennec Pharmaceuticals, Inc.

What is the status of "FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT"?

Its status at the USPTO is: registered.

When was "FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT" registered?

It was registered on January 23, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2aaf-845e-71f0-a272-6b54354ca35c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2aaf-845e-71f0-a272-6b54354ca35c",
  "object": "trademark",
  "mark_text": "FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97467771",
  "filing_date": "2022-06-21",
  "nice_classes": [
    35,
    44
  ],
  "owners": [
    {
      "name": "Fennec Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb70c-e447-74af-9302-d24346ffab56"
    }
  ]
}